About: Efficacy of adjuvant topical timolol-dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Efficacy of adjuvant topical timolol-dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 10 February 2019

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2019 (fr) im Februar 2019 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 2019 (ast) scientific article published on 10 February 2019 (en) 2019 թվականի փետրվարի 10-ին հրատարակված գիտական հոդված (hy) наукова стаття, опублікована 10 лютого 2019 (uk)
publication date	wds:Q91976487-5B624C9E-87AD-48D8-998D-F4EFA293DFD5
publication date	2019-02-10 00:00:00Z (xsd:dateTime)
cites work	wds:Q91976487-0B75955D-F72F-48CE-BA8A-23B917754ED4 wds:Q91976487-19F49538-04F6-4DB2-9FDC-BE4B0D0126CB wds:Q91976487-2B46C362-1F2E-459D-B442-A0A753FD42F7 wds:Q91976487-320C8EC5-1A5C-406F-9040-DF8E273203B0 wds:Q91976487-34F94C33-5C92-4728-842B-7A7A4F5C9EE4 wds:Q91976487-380971CD-9688-4944-A204-14489EA2A40B wds:Q91976487-3962208B-81D8-4BB0-9673-A4B9114CFA1E wds:Q91976487-400B198A-5A7E-40E2-9F6D-E894B9B46FBA wds:Q91976487-4804BC48-25A8-4D8D-9103-D99540D37399 wds:Q91976487-4C2BBD2B-AFB7-4B87-A4B8-D2EEB810F3CD wds:Q91976487-68695C42-91FF-4166-962E-EC00F4D4825F wds:Q91976487-68EEA02C-8A9F-41B3-8777-6EAFFDB1618A wds:Q91976487-6FF6E66A-17F3-4708-B4A6-871B9861AE9A wds:Q91976487-7084F7D3-8B97-45A1-A75F-07434B52E776 wds:Q91976487-763AE581-9F56-490F-9901-0CA325FE4ADD wds:Q91976487-77A2F051-7742-4E41-B0A0-54B987EEB539 wds:Q91976487-7BFAD751-FDB3-4DD9-B8BD-5693DE791F02 wds:Q91976487-854AB901-C75D-49A8-8550-9DFF87CCEF7A wds:Q91976487-8E8F90A0-23A5-49B9-AB17-66F45A03220E wds:Q91976487-B5EDCE03-3BF1-4A7A-8545-94D6114DD223 wds:Q91976487-DAA7E9C0-B713-4C79-8EB2-578868ADB03E wds:Q91976487-FE5F3B75-85A6-4161-92EA-3050CA168ED5
cites work	Attenuation of choroidal neovascularization by β(2)-adrenoreceptor antagonism Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis Retina Specialists Treating Diabetic Macular Edema Recommend Different Approaches for Patients Than They Would Choose for Themselves Diabetic macular edema: new concepts in patho-physiology and treatment Predicted biologic activity of intravitreal bevacizumab. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration Pharmacokinetics of intravitreal bevacizumab (Avastin) Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate The relative clinical effectiveness of ranibizumab and bevacizumab in diabetic macular oedema: an indirect comparison in a systematic review Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema Anti-vascular endothelial growth factor for diabetic macular oedema The effects of dorzolamide on choroidal and retinal perfusion in non-exudative age related macular degeneration. The β-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases Topical Dorzolamide-Timolol With Intravitreous Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration Prolongation of activity of single intravitreal bevacizumab by adjuvant topical aqueous depressant (Timolol-Dorzolamide). Membrane-bound carbonic anhydrase activity in the rat corneal endothelium and retina Comparison of the efficacy of betaxolol-brinzolamide and timolol-dorzolamide as suppressors of aqueous humor flow in human subjects Impact of intravitreal pharmacotherapies including antivascular endothelial growth factor and corticosteroid agents on diabetic retinopathy Topical nepafenec in eyes with noncentral diabetic macular edema Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome
author name string	wds:Q91976487-2A6B5616-0770-4F70-808B-C20BF7225812 wds:Q91976487-8F22887C-3355-418A-A5DF-B9999DE86034 wds:Q91976487-A1A36229-530F-4CA9-8D08-388624B6B3F8 wds:Q91976487-B9238CC2-DBA9-4D8C-A380-0A1AA5986712 wds:Q91976487-D04D2FC9-D763-468A-8025-56C04507FF87
author name string	Ramin Tadayoni Ahmad Mirshahi Mojtaba Abrishami Navid Mohsenzadeh Talieh Saeidi Rezvani
rdfs:label	Efficacy of adjuvant topical timolol-dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study (en) Efficacy of adjuvant topical timolol-dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study (nl)
skos:prefLabel	Efficacy of adjuvant topical timolol-dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study (en) Efficacy of adjuvant topical timolol-dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study (nl)
name	Efficacy of adjuvant topical timolol-dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study (en) Efficacy of adjuvant topical timolol-dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study (nl)
title	wds:Q91976487-D8C21B79-81AB-4E59-A401-6760F57BD4FB
title	Efficacy of adjuvant topical timolol-dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study (en)
page(s)	wds:Q91976487-12657592-E027-4E47-95D2-0317C9B8D297
page(s)	168-171
instance of	wds:Q91976487-257C0056-8F32-4AC5-AE83-BA36E172E456
instance of	scholarly article
main subject	wds:Q91976487-1E7FD361-128B-46C7-AFA0-A150C4405256 wds:Q91976487-55F9C553-F450-40BD-95DB-091FD0F614EA
main subject	bevacizumab diabetic macular edema
PubMed ID	wds:Q91976487-8DA248E2-B887-41BF-8A90-FFE494176CE1
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31317095
PubMed ID	31317095
published in	wds:Q91976487-74426EDF-AC48-4786-8844-081C1ECF7D47
published in	Journal of current ophthalmology
issue	wds:Q91976487-FF10751F-FD8E-47C4-847D-ABC5D410FF7C
volume	wds:Q91976487-95571E0E-1653-4C18-896B-8A516344E0CB
issue	2
volume	31
DOI	wds:Q91976487-21CAC44F-6B13-4DAF-AC80-61BAA9A8D5E1
DOI	http://dx.doi.org/10.1016/J.JOCO.2019.01.008
DOI	10.1016/J.JOCO.2019.01.008
PMCID	wds:Q91976487-82AE7926-8066-4B51-B3A6-6DEC235B3FDD
PMCID	6611985
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q91976487

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software